Alzheimer’s drug Lecanemab approved by Therapeutic Goods Administration for use in Australia

A promising new Alzheimer’s drug has been green-lit by the national medicines regulator, after two previous failed attempts to register it for use in Australia.

Lecanemab, sold under the brand name Leqembi, has been shown to clear amyloid plaque in the brain, which experts believe plays a role in…